Categories: India

Merck, Daiichi Sankyo withdraw US application for lung cancer drug

Sept 25 (Reuters) – Merck and Daiichi Sankyo have voluntarily withdrawn their US application seeking accelerated approval for their experimental lung cancer therapy, the drugmakers said on Friday. (

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

UPDATE 1-China leaves lending benchmarks unchanged for 18th straight month in November

(Adds details; paragraphs 2,6-10) SHANGHAI, Nov 20 (Reuters) - China kept its benchmark lending rates…

30 seconds ago

Fed's Paulson backs further rate hikes, says shared understanding beats guidance

By Michael S. Derby NEW YORK, Nov 19 (Reuters) - Federal Reserve Bank of Philadelphia…

5 minutes ago

Trump ousts cyber director after tech outages spark criticism

By Courtney Rozen WASHINGTON, Nov 19 (Reuters) - White House national cyber director Sean Cairncross was…

6 minutes ago

Motor racing-Nike to become Formula One's official apparel and uniform partner

By Rory Carroll LAS VEGAS, Nov 19 (Reuters) - Formula One's push to turn its…

8 minutes ago

PGA Tour-The RSM Classic 2026 The RSM Classic Scores

Nov 20 (OPTA) - Scores from the PGA Tour-The RSM Classic 2026 The RSM Classic…

12 minutes ago

US signed off on sales of nearly 900,000 AI chips to China in six months, House committee says

By Alexandra Alper, Katharine Jackson and Karen Freifeld WASHINGTON, Nov 19 (Reuters) - The Trump…

16 minutes ago